Skip to main content

Advertisement

SpringerLink
Log in

How should the clinician most effectively prevent type 2 diabetes in the obese person at high risk?

  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

Abstract

The dramatic increase in newly diagnosed cases of type 2 diabetes (T2D) has developed into a major public health concern worldwide. Conversely, several clinical studies have demonstrated that preventive efforts can significantly reduce the risk of developing diabetes. There is a clear consensus that action is needed to develop targeted community-based prevention programs and strategies for T2D. Currently, numerous prevention management concepts that can be implemented into clinical practice exist in various countries. Finland is the pioneer country in implementing community-wide diabetes prevention programs. Nevertheless, population-based nationwide strategies are still lacking in virtually all countries. We report on intervention strategies to prevent T2D in people with increased diabetes risk, as well as strategies on how to implement diabetes prevention programs into the real world of public health or clinical care. The implementation of managed prevention concepts will realistically help to improve the ability to prevent T2D in the public health framework.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. World Health Organization: Diet, nutrition, and the prevention of chronic disease. Report of a joint FAO/WHO consultation. Geneva: World Health Organization; 2003. WHO Technical Report Series No. 916.

    Google Scholar 

  2. Zimmet P, Alberti KG, Shaw J: Global and societal implications of the diabetes epidemic. Nature 2001, 414:782–787.

    Article  PubMed  CAS  Google Scholar 

  3. Zimmet P: The burden of type 2 diabetes: are we doing enough? Diabetes Metab 2003, 29(4 Pt 2):6S9–6S18.

    Article  PubMed  CAS  Google Scholar 

  4. Nestle M: Preventing childhood diabetes: the need for public health intervention. Am J Public Health 2005, 95:1497–1499.

    Article  PubMed  Google Scholar 

  5. Schwarz PE, Bornstein SR: Pre-diabetes and metabolic syndrome in Germans. Horm Metab Res 2006, 38:359.

    Article  PubMed  CAS  Google Scholar 

  6. Kanauchi M, Kawano T, Kanauchi K, Saito Y: New “prediabetes” category and the metabolic syndrome in Japanese. Horm Metab Res 2005, 37:622–626.

    Article  PubMed  CAS  Google Scholar 

  7. Valensi P, Schwarz EH, Hall M, et al.: Pre-diabetes essential action: a European perspective. Diabetes Metab 2005, 31:606–620.

    Article  PubMed  CAS  Google Scholar 

  8. Fox CS, Coady S, Sorlie PD, et al.: Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study. Circulation 2007, 115:1544–1550.

    Article  PubMed  Google Scholar 

  9. Trajkovski M, Mziaut H, Schwarz PE, Solimena M, et al.: Genes of type 2 diabetes in beta cells. Endocrinol Metab Clin North Am 2006, 35:357–369.

    Article  PubMed  CAS  Google Scholar 

  10. Gillies CL, Abrams KR, Lambert PC, et al.: Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ 2007, 334:299.

    Article  PubMed  Google Scholar 

  11. Alberti KG, Zimmet P, Shaw J: International Diabetes Federation: a consensus on type 2 diabetes prevention. Diabet Med 2007, 24:451–463.

    Article  PubMed  CAS  Google Scholar 

  12. Herman WH, Brandle M, Zhang P, et al.: Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program. Diabetes Care 2003, 26:36–47.

    Article  Google Scholar 

  13. Pan XR, Li GW, Hu YH, et al.: Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997, 20:537–544.

    Article  PubMed  CAS  Google Scholar 

  14. Tuomilehto J, Lindström J, Eriksson JG, et al.: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001, 344:1343–1350.

    Article  PubMed  CAS  Google Scholar 

  15. American Diabetes Association and National Institute of Diabetes, Digestive and Kidney Diseases: The prevention or delay of type 2 diabetes. Diabetes Care 2002, 25:742–749.

    Article  Google Scholar 

  16. Lindstrom J, Ilanne-Parikka P, Peltonen M, et al.: Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 2006, 368:1673–1679.

    Article  PubMed  Google Scholar 

  17. Lindstrom J, Peltonen M, Tuomilehto J: Lifestyle strategies for weight control: experience from the Finnish Diabetes Prevention Study. Proc Nutr Soc 2005, 64:81–88.

    Article  PubMed  Google Scholar 

  18. Knowler WC, Barrett-Connor E, Fowler SE, et al.: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346:393–403.

    Article  PubMed  CAS  Google Scholar 

  19. Ou HY, Cheng JT, Yu EH, Wu TJ: Metformin increases insulin sensitivity and plasma beta-endorphin in human subjects. Horm Metab Res 2006, 38:106–111.

    Article  PubMed  CAS  Google Scholar 

  20. Fujimoto WY, Jablonski KA, Bray GA, et al.: Body size and shape changes and the risk of diabetes in the diabetes prevention program. Diabetes 2007, 56:1680–1685.

    Article  PubMed  CAS  Google Scholar 

  21. Kitabchi AE, Temprosa M, Knowler WC, et al.: Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin. Diabetes 2005, 54:2404–2414.

    Article  PubMed  Google Scholar 

  22. Ramachandran A, Snehalatha C, Mary S, et al.: The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 2006, 49:289–297.

    Article  PubMed  CAS  Google Scholar 

  23. Chiasson JL, Josse RG, Gomis R, et al.: Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 2002, 359:2072–2077.

    Article  PubMed  CAS  Google Scholar 

  24. Torgerson JS, Hauptman J, Boldrin MN, Sjöström L: XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 2004, 27:155–161.

    Article  PubMed  CAS  Google Scholar 

  25. Gerstein HC, Yusuf S, Bosch J, et al.: Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet 2006, 368:1096–1105.

    Article  PubMed  CAS  Google Scholar 

  26. Bosch J, Yusuf S, Gerstein HC, et al.: Effect of ramipril on the incidence of diabetes. N Engl J Med 2006, 355:1551–1562.

    Article  PubMed  Google Scholar 

  27. Abuissa H, Jones PG, Marso SP, O’Keefe JH: Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials. J Am Coll Cardiol 2005, 46:821–826.

    Article  PubMed  CAS  Google Scholar 

  28. Chiasson JL, Brindisi MC, Rabasa-Lhoret R: The prevention of type 2 diabetes: what is the evidence? Minerva Endocrinol 2005, 30:179–191.

    PubMed  CAS  Google Scholar 

  29. Freeman DJ, Norrie J, Sattar N, et al.: Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study. Circulation 2001, 103:357–362.

    PubMed  CAS  Google Scholar 

  30. Tuomilehto J: Counterpoint: Evidence-based prevention of type 2 diabetes: the power of lifestyle management. Diabetes Care 2007, 30:435–438.

    Article  PubMed  Google Scholar 

  31. Hill JO, Stuht J, Wyatt HR, Regensteiner JG: Physical activity in prevention and management of obesity and type-2 diabetes. Nestle Nutr Workshop Ser Clin Perform Programme 2006, 11:183–191; discussion 191–196.

    PubMed  Google Scholar 

  32. Hu G, Lakka TA, Kilpeläinen TO, Tuomilehto J: Epidemiological studies of exercise in diabetes prevention. Appl Physiol Nutr Metab 2007, 32:583–595.

    Article  PubMed  Google Scholar 

  33. Lindstrom J, Peltonen M, Eriksson JG, et al.: High-fibre, low-fat diet predicts long-term weight loss and decreased type 2 diabetes risk: the Finnish Diabetes Prevention Study. Diabetologia, 2006, 49:912–920.

    Article  PubMed  CAS  Google Scholar 

  34. Crandall J, Schade D, Ma Y, et al.: The influence of age on the effects of lifestyle modification and metformin in prevention of diabetes. J Gerontol A Biol Sci Med Sci 2006, 61:1075–1081.

    PubMed  Google Scholar 

  35. Buchanan TA: (How) can we prevent type 2 diabetes? Diabetes 2007, 56:1502–1507.

    Article  PubMed  CAS  Google Scholar 

  36. Schwarz PE, Schwarz J, Schuppenies A, et al.: Development of a diabetes prevention management program for clinical practice. Public Health Rep 2007, 122:258–263.

    PubMed  Google Scholar 

  37. Saaristo T, Peltonen M, Keinänen-Kiukaanniemi S, et al.: National type 2 diabetes programme in Finland: FIN-D2D. Int J Circumpolar Health 2007, 66:101–112.

    PubMed  Google Scholar 

  38. Bazzano LA, He J, Ogden LG, et al.: Dietary fiber intake and reduced risk of coronary heart disease in US men and women: the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Arch Intern Med 2003, 163:1897–1904.

    Article  PubMed  Google Scholar 

  39. Watts G: Huge numbers must change lifestyle to prevent epidemic of diabetes. BMJ 2003, 327:1365.

    Article  PubMed  Google Scholar 

  40. Narayan KM, Bowman BA, Engelgau ME: Prevention of type 2 diabetes. BMJ 2001, 323:63–64.

    Article  PubMed  CAS  Google Scholar 

  41. Schwarz PE, Schwarz J, Bornstein SR, Schulze J: Diabetes prevention—from physiology to implementation. Horm Metab Res 2006, 38:460–464.

    Article  PubMed  CAS  Google Scholar 

  42. Icks A, Rathmann W, Haastert B, et al.: Clinical and cost-effectiveness of primary prevention of type 2 diabetes in a “real world” routine healthcare setting: model based on the KORA Survey 2000. Diabet Med 2007, 24:473–480.

    Article  PubMed  CAS  Google Scholar 

  43. Ackermann RT, Marrero DG: Adapting the Diabetes Prevention Program lifestyle intervention for delivery in the community: the YMCA model. Diabetes Educ 2007, 33:69, 74–75, 77–78.

    Article  PubMed  Google Scholar 

  44. Boltri JM, Okosun I, Davis-Smith YM, et al.: A simple nurse-based prompt increases screening and prevention counseling for diabetes. Diabetes Res Clin Pract 2007, 75:81–87.

    Article  PubMed  Google Scholar 

  45. Smith-Ray RL, Almeida FA, Bajaj J, et al.: Translating efficacious behavioral principles for diabetes prevention into practice. Health Promot Pract 2007, May 9; [Epub ahead of print.]

  46. The Finnish Diabetes Association: Programme for the Prevention of Type 2 Diabetes in Finland 2003–2010. Available at http://www.diabetes.fi/tiedoston_katsominen.php/?dok_id=179. Accessed August 2, 2007.

  47. Lindstrom J, Tuomilehto J: The Diabetes Risk Score: a practical tool to predict type 2 diabetes risk. Diabetes Care 2003, 26:725–731.

    Article  PubMed  Google Scholar 

  48. Saaristo T, Peltonen M, Lindström J, et al.: Cross-sectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome. Diab Vasc Dis Res 2005, 2:67–72.

    Article  PubMed  Google Scholar 

  49. Hauner H, Landgraf R, Schulze J, et al.: [Prevention of type 2 diabetes mellitus. Position paper of the National Action Forum for Diabetes Mellitus]. Dtsch Med Wochenschr 2005, 130:1053–1054.

    Article  PubMed  CAS  Google Scholar 

  50. Schwarz PE, Gruhl U, Schuppenies A, et al.: Prevention of diabetes mellitus: the future of German diabetology. Hamostaseologie 2007, 27:13–21.

    PubMed  CAS  Google Scholar 

  51. Roubideaux Y, Buchwald D, Beals J, et al.: Measuring the quality of diabetes care for older American Indians and Alaska natives. Am J Public Health 2004, 94:60–65.

    Article  PubMed  Google Scholar 

  52. Hamman RF, Wing RR, Edelstein SL, et al: Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care 2006, 29:2102–2107.

    Article  PubMed  Google Scholar 

  53. Hu FB, van Dam RM, Liu S: Diet and risk of type II diabetes: the role of types of fat and carbohydrate. Diabetologia 2001, 44:805–817.

    Article  PubMed  CAS  Google Scholar 

  54. Weickert MO, Mohlig M, Schofl C, et al.: Cereal fiber improves whole-body insulin sensitivity in overweight and obese women. Diabetes Care 2006, 29:775–780.

    Article  PubMed  CAS  Google Scholar 

  55. Schulze MB, Liu S, Rimm EB, et al.: Glycemic index, glycemic load, and dietary fiber intake and incidence of type 2 diabetes in younger and middle-aged women. Am J Clin Nutr 2004, 80:348–356.

    PubMed  CAS  Google Scholar 

  56. Tuomilehto J, Hu G, Bidel S, et al: Coffee consumption and risk of type 2 diabetes mellitus among middle-aged Finnish men and women. JAMA 2004, 291:1213–1219.

    Article  PubMed  CAS  Google Scholar 

  57. Hodge AM, English DR, O’Dea K, Giles GG: Alcohol intake, consumption pattern and beverage type, and the risk of type 2 diabetes. Diabet Med 2006, 23:690–697.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Public Health, University of Helsinki, Mannerheimintie 172, 00300, Helsinki, Finland

    Jaakko Tuomilehto

Authors
  1. Peter E. H. Schwarz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jiang Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jaana Lindström
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Antje Bergmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ulrike Gruhl
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Timo Saaristo
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jaakko Tuomilehto
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jaakko Tuomilehto.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schwarz, P.E.H., Li, J., Lindström, J. et al. How should the clinician most effectively prevent type 2 diabetes in the obese person at high risk?. Curr Diab Rep 7, 353–362 (2007). https://doi.org/10.1007/s11892-007-0058-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11892-007-0058-7

Keywords

Search

Navigation